Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Melissa Officinalis
Therapeutic Area : Psychiatry/Psychology
Study Phase : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
December 27, 2023
Lead Product(s) : Melissa Officinalis
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Melissa Officinalis
Therapeutic Area : Sleep
Study Phase : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 16, 2022
Lead Product(s) : Melissa Officinalis
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aronia
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Colorado State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Aronia
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Colorado State University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Cranberry
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Recipient : Laval University
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
November 27, 2018
Lead Product(s) : Cranberry
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Recipient : Laval University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aronia Extract
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
To Assess the Influence of Aronox on Parameters Associated With Aerobic Performance
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 05, 2018
Lead Product(s) : Aronia Extract
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : Northumbria University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Ginseng Extract
Therapeutic Area : Neurology
Study Phase : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 06, 2018
Lead Product(s) : Ginseng Extract
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Recipient : University of Reading
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Grape Extract
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 12, 2018
Lead Product(s) : Grape Extract
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aronia Extract
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Aronia Berry Consumption on Blood Pressure
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 15, 2018
Lead Product(s) : Aronia Extract
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aronia
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Aronia Berry Consumption on Vascular Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 03, 2017
Lead Product(s) : Aronia
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Recipient : King's College London
Deal Size : Inapplicable
Deal Type : Inapplicable
Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 11, 2017